Table 3:
Pooled SIR | 95% CI | I2 | |
---|---|---|---|
All Gastric Cancer | |||
Female (n=10) 27, 28, 29, 40, 43, 44, 45, 73, 76, 77 | 1.83 | (1.69–1.98) | 29.5 |
Male (n=11) 24, 27, 28, 29, 40, 43, 44, 45, 73, 76, 77 | 1.66 | (1.52–1.80) | 70.1 |
High risk Gastric Cancer* | |||
Female (n=9) 27, 28, 29, 40, 43, 44, 45, 73, 76 | 1.83 | (1.68–1.97) | 29.7 |
Male (n=10) 24, 27, 28, 29, 40, 43, 44, 45, 73, 76 | 1.66 | (1.52–1.81) | 70.7 |
Anatomic Subtypes | |||
Noncardia Gastric Cancer or Unspecified | |||
Female (n=9) 27, 28, 29, 40, 44, 45, 73, 76, 77 | 1.80 | (1.65–1.95) | 33.9 |
Male (n=10) 24, 27, 28, 29, 40, 44, 45, 73, 76, 77 | 1.62 | (1.47–1.76) | 70.2 |
Noncardia Gastric Cancer | |||
Female (n=3) 40,44,45 | 1.80 | (1.56–2.05) | 10.4 |
Male (n=3) 40,44,45 | 1.56 | (1.21–1.91) | 80.8 |
Cardia Gastric Cancer | |||
Female (n=3) 40,44,45 | 1.69 | (1.13–2.25) | 68.5 |
Male (n=3) 40,44,45 | 1.67 | (1.17–2.18) | 66.3 |
• Abbreviations: Standardized Incidence Ratio (SIR)
• Non-cardia, unspecified, intestinal type, or adenocarcinoma